CAXTON ASSOCIATES LP - EMERGENT BIOSOLUTIONS INC ownership

EMERGENT BIOSOLUTIONS INC's ticker is EBS and the CUSIP is 29089Q105. A total of 197 filers reported holding EMERGENT BIOSOLUTIONS INC in Q4 2022. The put-call ratio across all filers is 0.38 and the average weighting 0.0%.

Quarter-by-quarter ownership
CAXTON ASSOCIATES LP ownership history of EMERGENT BIOSOLUTIONS INC
ValueSharesWeighting
Q2 2023$369,448
-52.4%
50,265
-32.9%
0.06%
-53.0%
Q1 2023$776,306
+404.7%
74,933
+475.3%
0.12%
+1070.0%
Q4 2022$153,825
-56.7%
13,025
-23.1%
0.01%
-78.7%
Q3 2022$355,000
-31.6%
16,932
+1.3%
0.05%
-6.0%
Q2 2022$519,000
+90.8%
16,719
+534.0%
0.05%
+72.4%
Q3 2020$272,000
-46.6%
2,637
-59.0%
0.03%
-34.1%
Q2 2020$509,0006,4340.04%
Other shareholders
EMERGENT BIOSOLUTIONS INC shareholders Q4 2022
NameSharesValueWeighting ↓
Zebra Capital Management LLC 22,111$908,0002.08%
Global Alpha Capital Management Ltd. 460,530$18,909,0001.62%
AIMZ Investment Advisors, LLC 70,625$2,900,0001.19%
Bridge City Capital, LLC 39,835$1,636,0000.76%
PALISADE CAPITAL MANAGEMENT, LP 560,409$23,010,0000.53%
EARNEST PARTNERS LLC 2,071,376$85,051,0000.50%
RICE HALL JAMES & ASSOCIATES, LLC 302,721$12,430,0000.50%
SummerHaven Investment Management, LLC 14,476$594,0000.34%
Ridgewood Investments LLC 10,004$411,0000.27%
AtonRa Partners 11,505$472,0000.26%
View complete list of EMERGENT BIOSOLUTIONS INC shareholders